Surgery Partners (SGRY)
(Delayed Data from NSDQ)
$22.03 USD
+0.24 (1.10%)
Updated Sep 18, 2025 04:00 PM ET
After-Market: $22.03 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth B Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
Currently, Surgery Partners, Inc. has a PEG ratio of 15.67 compared to the Medical Services industry's PEG ratio of 1.34.
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
SGRY 22.03 +0.24(1.10%)
Will SGRY be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for SGRY based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SGRY
Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
Danaher (DHR) Q2 Earnings and Revenues Top Estimates
SGRY: What are Zacks experts saying now?
Zacks Private Portfolio Services
Surgery Partners (SGRY) Q1 Earnings and Revenues Miss Estimates
Co-Diagnostics, Inc. (CODX) Reports Q1 Loss, Misses Revenue Estimates
Alignment Healthcare (ALHC) Reports Q1 Loss, Tops Revenue Estimates
Other News for SGRY
Aveanna upgraded at J.P. Morgan on risk-reward setup
SGRY rises 1.07% on September 17, leaving the technical picture intact
SGRY: JP Morgan Initiates Coverage with 'Neutral' Rating | SGRY Stock News
Surgery Partners assumed with a Neutral at JPMorgan
Surgery Partners assumed with a Neutral at JPMorgan